May 05, 2021 12:43 PM IST
Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.
- May 04, 2021 02:23 PM IST
So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.
- May 04, 2021 08:52 AM IST
The B.1.617 variant is also being called a 'double mutant' or the 'Indian strain'.
- May 01, 2021 10:07 AM IST
Covaxin has received Emergency Use Authorisation in several countries across the globe with another 60 in process.
- Apr 30, 2021 11:10 AM IST
The cumulative number of COVID-19 vaccine doses administered in the country stands at 15,21,05,563.
- Apr 30, 2021 08:16 AM IST
BMC said the vaccination drive for the 18-44 age group, scheduled to begin from May 1 earlier, was likely to be deferred.
- Apr 29, 2021 05:55 PM IST
Bharat Biotech had earlier set Covaxin’s price at Rs 600 per dose for state governments. The company decided to reduce the price in view of the enormous challenges the second wave of the pandemic has posed for the public healthcare systems.
- Apr 29, 2021 12:28 PM IST
The Centre has decided to open up the vaccination drive for everyone above 18 from May 1 onwards.
- Apr 28, 2021 06:48 PM IST
The state government announced that of the one crore vaccines to be purchased, 70 lakh doses will be Covishield and 30 lakh Covaxin. The said number of doses will be procured between May and July for Rs 483 crore.
- Apr 28, 2021 07:53 AM IST
White House chief medical adviser Dr Anthony Fauci said COVID-19 vaccination could be a very important antidote to the pandemic difficulty being seen India.
- Apr 28, 2021 07:34 AM IST
Coronavirus News Highlights: Registering a steady increase, the active cases have risen to 29,78,709, comprising 16.55 percent of the total infections
- Apr 27, 2021 10:53 PM IST
Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology (IGIB), said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.
- Apr 27, 2021 03:30 PM IST
If such public money has been used in the development of COVID-19 vaccines, there should be enough transparency in the pricing of these vaccines, too
- Apr 25, 2021 10:10 PM IST
The state government will buy one crore doses of Covishield vaccine from Pune's Serum Institute of India and 50 lakh doses of Covaxin from Bharat Biotech in Hyderabad, an official release said.
- Apr 25, 2021 08:22 PM IST
Chahal said that Covaxin will be available only at select centres for the second dose due to 'extremely limited' existing stock.
- Apr 24, 2021 10:15 PM IST
Bharat Biotech further announced that it will also export Covaxin and the export price of the vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 per dose, approximately.
- Apr 23, 2021 11:16 AM IST
On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.
- Apr 22, 2021 10:14 AM IST
The year that started out on a sizzling note has fizzled out, with only the pharma sector - naturally - emerging as the top performer, quite like 2020
- Apr 21, 2021 05:08 PM IST
Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India.
- Apr 21, 2021 03:19 PM IST
Due to the recent surge in cases, 127 symptomatic cases were recorded, resulting in a point estimate of vaccine efficacy of 78 percent against mild, moderate, and severe COVID-19 disease, the company said.
- Apr 21, 2021 12:22 PM IST
Bharat Biotch expects to reach a production capacity of up to 800 million doses per annum by July-August.
- Apr 20, 2021 05:45 PM IST
Many who received the first dose in the first week of March when the vaccination drive started are supposed to take the second dose this week or in the next few days.
- Apr 20, 2021 03:10 PM IST
The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 700 million doses per year, which are one of the largest production capacities for inactivated viral vaccines worldwide.
- Apr 20, 2021 10:11 AM IST
Dr Reddy’s, Gland Pharma, Strides, Cadila, Aurobindo are some of the names that merit a close watch as operating leverage plays out
- Apr 19, 2021 09:19 PM IST
“The Finance Ministry today has relaxed the general financial rules and permitted the Ministry of Health to pay, if they so wish, to make advance payment to vaccine suppliers, without a bank guarantee. I believe the Health Ministry is already doing so,” a top official told Moneycontrol